Ribomic Inc.
(株)リボミック
2026/10/12 19:39 Updated
Market Cap:
$25.4M (¥4.0B)
Stock Price:
$0.45 (¥71)
Exchange Rate: 1 USD = ¥158.23
Supplementary description on the design and safety of a domestic Phase III clinical trial of achondroplasia treatment drug (umedaptanib pegol)
Ribomic Inc.
Company overview · Stock price · Financial data · All IR
